You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 11, November 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Article
 This Article
 •Full text
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (33)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Lipids and Lipid Disorders
 •Complementary and Alternative Medicine
 •Alert me on articles by topic

Garlic Extract Therapy in Children With Hypercholesterolemia

Brian W. McCrindle, MD, MPH, FRCPC; Elizabeth Helden, BSN, MEd; William T. Conner, MBBS, MRCP, FRCPC

Arch Pediatr Adolesc Med. 1998;152:1089-1094.

Objective  To determine whether garlic extract therapy is efficacious and safe in children with hypercholesterolemia.

Design  Randomized, double-blind, placebo-controlled clinical trial.

Setting  Specialized pediatric lipid disorders ambulatory clinic.

Participants  Thirty pediatric patients, aged 8 to 18 years, who had familial hyperlipidemia and a minimum fasting total cholesterol level greater than 4.8 mmol/L (>185 mg/dL).

Intervention  An 8-week course of a commercially available garlic extract (Kwai [Lichtwer Pharma, Berlin, Germany], 300 mg, 3 times a day) or an identical placebo.

Main Outcome Measures  Absolute and relative changes in fasting lipid profile parameters.

Results  The groups were equivalent at baseline and compliance was similar in the 2 groups (P=.45). There was no significant relative attributable effect of garlic extract on fasting total cholesterol (+0.6% [95% confidence interval, -5.8% to +6.9%]) or low-density lipoprotein cholesterol (-0.5% [95% confidence interval, -8.7% to +7.6%]). The lower limits of the confidence intervals did not include -10%, the minimum relative attributable effect believed to be clinically important. Likewise, no significant effect was seen on the levels of high-density lipoprotein, triglycerides, apolipoprotein B-100, lipoprotein(a), fibrinogen, homocysteine, or blood pressure. There was a small effect on apolipoprotein A-I (+10.0% [95% confidence interval, +1.2% to +16.5%] P=.03). There were no differences in adverse effects between groups.

Conclusion  Garlic extract therapy has no significant effect on cardiovascular risk factors in pediatric patients with familial hyperlipidemia.


From the Department of Pediatrics, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, (Dr McCrindle); and the Department of Pediatrics, McMaster University, St Joseph's Hospital, Hamilton, Ontario (Ms Helden and Dr Conner).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Review: Management of dyslipidemia in children and adolescents with systemic lupus erythematosus
Ardoin et al.
Lupus 2007;16:618-626.
ABSTRACT  

Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force
Haney et al.
Pediatrics 2007;120:e189-e214.
ABSTRACT | FULL TEXT  

Screening for Lipid Disorders in Children: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
Pediatrics 2007;120:e215-e219.
FULL TEXT  

Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing
McCrindle et al.
Circulation 2007;115:1948-1967.
ABSTRACT | FULL TEXT  

Effect of Raw Garlic vs Commercial Garlic Supplements on Plasma Lipid Concentrations in Adults With Moderate Hypercholesterolemia: A Randomized Clinical Trial
Gardner et al.
Arch Intern Med 2007;167:346-353.
ABSTRACT | FULL TEXT  

Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics
Kavey et al.
Circulation 2006;114:2710-2738.
ABSTRACT | FULL TEXT  

Complementary, Holistic, and Integrative Medicine: Garlic
Shamseer et al.
Pediatr. Rev. 2006;27:e77-e80.
FULL TEXT  

Gender May Affect the Action of Garlic Oil on Plasma Cholesterol and Glucose Levels of Normal Subjects
Zhang et al.
J. Nutr. 2001;131:1471-1478.
ABSTRACT | FULL TEXT  

Garlic Shows Promise for Improving Some Cardiovascular Risk Factors
Ackermann et al.
Arch Intern Med 2001;161:813-824.
ABSTRACT | FULL TEXT  

Intake of Garlic and Its Bioactive Components
Amagase et al.
J. Nutr. 2001;131:955S-962.
ABSTRACT | FULL TEXT  

Garlic for Treating Hypercholesterolemia: A Meta-Analysis of Randomized Clinical Trials
Stevinson et al.
ANN INTERN MED 2000;133:420-429.
ABSTRACT | FULL TEXT  

Herbs in Pediatric and Adolescent Medicine
Gardiner and Kemper
Pediatr. Rev. 2000;21:44-57.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.